Wellbutrin (bupropion) passes into breast milk in small amounts and is not expected to cause harmful effects for most breastfed infants. However, it carries a rare but serious risk: two case reports describe seizures in 6-month-old babies exposed to bupropion through breast milk, with seizures stopping once the medication was discontinued. This puts bupropion in a middle category among antidepressants used during breastfeeding, where it’s not considered first-line but isn’t ruled out either.
How Much Reaches the Baby
Bupropion transfers into breast milk, but the amounts are generally low. In the small number of published case studies where researchers tested infant blood, neither bupropion nor its active breakdown products were detectable in the babies’ bloodstreams. One early case report did note a relatively high ratio of the drug in milk compared to maternal blood, which initially raised concern. But measurable drug in milk doesn’t automatically mean measurable drug in the infant, since babies metabolize and clear substances differently.
The fact that blood levels in exposed infants have consistently come back below the threshold of detection is reassuring. It suggests that for most healthy, full-term infants, the exposure through nursing is minimal enough that their bodies handle it without accumulating significant amounts.
The Seizure Risk
The most concerning signal comes from two reported cases of seizures in 6-month-old infants whose mothers were taking bupropion while breastfeeding. In both cases, the seizures resolved after the mothers stopped the medication. Before these reports, three earlier case studies of breastfed infants and toddlers exposed to bupropion had found no adverse effects at all.
Bupropion is known to lower the seizure threshold in adults, so the possibility that it could do the same in infants isn’t entirely surprising. The risk appears to be rare, but because the total number of studied cases is small, it’s difficult to pin down exactly how rare. Infant seizures can look very different from what most people picture. Rather than full-body convulsions, they may show up as unusual eye movements (rolling or fluttering), repetitive sucking or chewing motions, leg pedaling, staring spells, or prolonged pauses in breathing.
Premature infants or newborns in the first few weeks of life may be more vulnerable because their ability to process and clear medications is less developed than that of older infants.
How It Compares to Other Antidepressants
Among antidepressants commonly used during breastfeeding, SSRIs like sertraline and paroxetine have the most safety data and the lowest measured levels in infant blood. They are generally considered the preferred options when a breastfeeding parent needs antidepressant treatment. Bupropion has fewer published studies behind it, which makes the safety picture less complete.
That said, bupropion works through a different mechanism than SSRIs. It primarily affects dopamine and norepinephrine rather than serotonin. For some people, it’s the only medication that effectively manages their depression, or it’s specifically chosen because it avoids side effects common with SSRIs like weight gain or sexual dysfunction. In those situations, the conversation shifts from “is there a safer option” to “do the benefits of this specific medication outweigh the small known risks.”
Extended-Release vs. Sustained-Release
Wellbutrin comes in three formulations: immediate-release (IR), sustained-release (SR), and extended-release (XL). The XL version reaches peak blood levels about 5 hours after taking it. Clinical studies show that the XL taken once daily and the SR taken twice daily produce equivalent peak concentrations and overall drug exposure over the course of a day.
Some breastfeeding parents try to time feedings around when the drug is at its lowest level in their blood. With the XL formulation, this would mean nursing right before taking your dose, when levels from the previous day’s pill are at their lowest. In practice, though, the difference this makes is likely modest given how little of the drug reaches infant blood in the first place. The extended-release formulation does produce a smoother, less spiky drug level throughout the day compared to immediate-release, which could theoretically mean more consistent (and lower peak) transfer into milk.
Practical Considerations
If you’re currently taking Wellbutrin and breastfeeding, or planning to, the key factors that influence risk include your baby’s age and health. Newborns and preterm infants clear medications more slowly, so exposure during the first few weeks of life carries more theoretical risk than exposure to a 4- or 6-month-old with more mature liver function. Your dose also matters: higher doses mean more drug available to transfer into milk.
Stopping an antidepressant that’s working well carries its own risks. Untreated postpartum depression affects bonding, caregiving, and maternal health in ways that can be more harmful to a baby’s development than low-level medication exposure through breast milk. The decision isn’t simply “medication vs. no medication” but a weighing of competing risks.
If you and your prescriber decide to continue bupropion while nursing, monitoring your baby for unusual symptoms is reasonable. Watch for changes in feeding patterns, excessive sleepiness, irritability, or any of the seizure signs described above: unusual eye movements, repetitive mouth movements, staring episodes, or pauses in breathing. These warrant prompt medical evaluation regardless of medication exposure.